Careers

Year: 2024

Group 11

Tabuk Pharmaceuticals Partners with Bio-Thera Solutions forRights to Manufacture and Commercialize BAT2206,a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

Manufacturing Company (a fully-owned subsidiary of Astra Industrial Group), a leading pharmaceutical company in the Middle East and North Africa (MENA) region, today announced the signing of a license, manufacturing, supply and commercialization agreement with Bio-Thera Solutions Inc. (688177:SH), a commercial-stage…

Read More
تنزيل (13)

TABUK AND HK INNO.N PARTNER TO BRING K-CAB® (TEGOPRAZAN) AN INNOVATIVE MEDICINE TO THE MENA REGION.

Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, announced today an exclusive license agreement with HK inno.N, a leading Korean pharmaceuticals company, to commercialize Tegoprazan, a novel potassium-competitive acid blocker…

Read More